California State Teachers Retirement System Myovant Sciences Ltd. Transaction History

California State Teachers Retirement System

  • $84.1 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$24.03 - $27.02 $15,595 - $17,535
649 Added 1.76%
37,561 $1.01 Million
Q3 2022

Nov 18, 2022
BUY
$11.6 - $20.44 $10,695 - $18,845
922 Added 2.56%
36,912 $663,000
Q2 2022

Aug 15, 2022
BUY
$7.78 - $14.69 $26,732 - $50,474
3,436 Added 10.55%
35,990 $447,000
Q1 2022

May 16, 2022
BUY
$11.38 - $16.4 $16,501 - $23,779
1,450 Added 4.66%
32,554 $434,000
Q4 2021

Feb 15, 2022
BUY
$14.31 - $23.87 $16,213 - $27,044
1,133 Added 3.78%
31,104 $484,000
Q3 2021

Nov 15, 2021
BUY
$18.94 - $26.99 $567,650 - $808,917
29,971 New
29,971 $673,000

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email